Sign In
Buy KDMN
$9.50
+0 (+0%)
At Close: Aug 17, 2022
LOS ANGELES--(BUSINESS WIRE)---- $KDMN #KDMN--SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Kadmon Holdings, Inc.
Atlanta, Georgia--(Newsfile Corp. - April 5, 2021) - Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased Kadmon Holdings Inc. (NASDAQ: KDMN)
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Kadmon Holdings, Inc. (NA
Pomerantz Law Firm Announces the Filing of a Class Action against Kadmon Holdings, Inc., and Certain Officers - KDMN
07:42pm, Saturday, 03'rd Apr 2021
NEW YORK, April 3, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Kadmon Holdings, Inc. ("Kadmon" or the "Company") (NASDAQ: KDMN) and certain of its
Kadmon Announces Trial-In-Progress Poster on KD033 at the 2021 American Association for Cancer Research Annual Meeting
08:00am, Thursday, 25'th Mar 2021
NEW YORK, NY / ACCESSWIRE / March 25, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced it will present a trial-in-progress poster on KD033-101, the Company's ongoing dose-escalation, dose-ex
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kadmon Holdings, Inc. - KDMN
08:10pm, Sunday, 14'th Mar 2021
New York, New York--(Newsfile Corp. - March 14, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Kadmon Holdings, Inc. ("Kadmon" or the "Company") (NASDAQ: KDMN). Such investors
Decision On Kadmon's Belumosudil US Application In Chronic GVHD Pushed Back By Three Months
06:40am, Thursday, 11'th Mar 2021
The FDA has extended the review period for Kadmon Holdings Inc's (NASDAQ: KDMN) marketing application seeking approval for belumosudil to treat chronic graft-versus-host disease (cGVHD). The goal
Kadmon Announces U.S. FDA Has Extended the Review Period for Belumosudil in Chronic Graft-Versus-Host Disease
04:14pm, Wednesday, 10'th Mar 2021
NEW YORK, NY / ACCESSWIRE / March 10, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Appli
Kadmon Holdings, Inc. (KDMN) Reports Q4 Loss, Tops Revenue Estimates
09:59pm, Thursday, 04'th Mar 2021
Kadmon Holdings, Inc. (KDMN) delivered earnings and revenue surprises of 0.00% and 37.89%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock
Kadmon Provides Business Update and Reports Fourth Quarter 2020 Financial Results
04:01pm, Thursday, 04'th Mar 2021
NEW YORK, NY / ACCESSWIRE / March 4, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today provided a business update and reported financial and operational results for the fourth quarter and full year end
Kadmon Looks Highly Investable Before PDUFA
08:00am, Friday, 19'th Feb 2021
Kadmon Looks Highly Investable Before PDUFA
5 Stocks to Buy Now Trading Under $10 With Plenty of Upside Potential
06:15am, Saturday, 13'th Feb 2021
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
Steven Cohen Boosts Kadmon Holdings Stake
04:42pm, Friday, 15'th Jan 2021
Steven Cohen ( Trades , Portfolio ) has revealed a large addition to his stake in Kadmon Holdings Inc. (NASDAQ:KDMN) according to GuruFocus' Real-Time Picks, a Premium feature.
Tracking Dan Loeb's Third Point Portfolio - Q2 2020 Update
09:36am, Friday, 28'th Aug 2020
Dan Loeb's 13F portfolio value increased from $6.27B to $7.30B this quarter. The number of positions increased from 30 to 36.
Kadmon Announces Appointment of Nancy Miller-Rich to Board of Directors
08:15pm, Thursday, 13'th Aug 2020
NEW YORK, NY / ACCESSWIRE / August 13, 2020 / Kadmon Holdings, Inc.
